Open Access
MolBank, volume 2021, issue 2, pages M1229
7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one
Chmovzh Timofey N
1, 2
,
Rakitin Oleg A.
1, 2
Publication type: Journal Article
Publication date: 2021-06-05
DOI:
10.3390/M1229
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Abstract
New heterocyclic systems containing 1,2,5-chalcogenadiazoles are of great interest for the creation of organic photovoltaic materials and biologically active compounds. In this communication, 3,6-dibromopyridazine-4,5-diamine was investigated in reaction with selenium dioxide in order to obtain 4,7-dibromo-[1,2,5]selenadiazolo[3,4-d]pyridazine. We found that 7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5H)-one, the first representative of the new heterocyclic system, was isolated as a hydrolysis product of the corresponding 4,7-dibromoderivative. The structure of the newly synthesized compound was established by means of elemental analysis, high-resolution mass spectrometry, 1H, 13C NMR, IR and UV spectroscopy, and mass spectrometry.
Citations by journals
1
|
|
MolBank
|
MolBank
1 publication, 100%
|
1
|
Citations by publishers
1
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 100%
|
1
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2021],"ids":[0],"codes":[0],"imageUrls":[""],"datasets":[{"label":"Citations number","data":[1],"backgroundColor":["#3B82F6"],"percentage":["100"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["MolBank"],"ids":[20017],"codes":[0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[1],"backgroundColor":["#3B82F6"],"percentage":[100],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Multidisciplinary Digital Publishing Institute (MDPI)"],"ids":[202],"codes":[0],"imageUrls":["\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp"],"datasets":[{"label":"","data":[1],"backgroundColor":["#3B82F6"],"percentage":[100],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Chmovzh T. N. et al. 7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one // MolBank. 2021. Vol. 2021. No. 2. p. M1229.
GOST all authors (up to 50)
Copy
Chmovzh T. N., Rakitin O. A. 7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one // MolBank. 2021. Vol. 2021. No. 2. p. M1229.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/M1229
UR - https://doi.org/10.3390%2FM1229
TI - 7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one
T2 - MolBank
AU - Chmovzh, Timofey N
AU - Rakitin, Oleg A.
PY - 2021
DA - 2021/06/05 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - M1229
IS - 2
VL - 2021
SN - 1422-8599
ER -
Cite this
BibTex
Copy
@article{2021_Chmovzh,
author = {Timofey N Chmovzh and Oleg A. Rakitin},
title = {7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one},
journal = {MolBank},
year = {2021},
volume = {2021},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {jun},
url = {https://doi.org/10.3390%2FM1229},
number = {2},
pages = {M1229},
doi = {10.3390/M1229}
}
Cite this
MLA
Copy
Chmovzh, Timofey N., et al. “7-bromo-[1,2,5]selenadiazolo[3,4-d]pyridazin-4(5h)-one.” MolBank, vol. 2021, no. 2, Jun. 2021, p. M1229. https://doi.org/10.3390%2FM1229.
Profiles